News | Heart Failure | March 03, 2023

Rutgers Researchers Use Artificial Intelligence to Predict Cardiovascular Disease

Machine learning can be used to help clinicians with early diagnosis

Machine learning can be used to help clinicians with early diagnosis

Getty Images


March 3, 2023 —  Researchers may be able to predict cardiovascular disease – such as atrial fibrillation and heart failure – in patients by using artificial intelligence (AI) to examine the genes in their DNA, according to a new Rutgers study. 

“With the successful execution of our model, we predicted the association of highly significant cardiovascular disease genes tied to demographic variables like race, gender and age.” said Zeeshan Ahmed, a core faculty member at the Rutgers Institute for Health, Health Care Policy and Aging Research (IFH) and lead author of the study, published in Genomics. 

According to the World Health Organization, cardiovascular disease is the leading cause of death globally, yet it is estimated that more than 75 percent of premature cardiovascular disease is preventable. Atrial fibrillation and heart failure contribute to about 45 percent of all cardiovascular disease deaths. 

Despite significant advancements in cardiovascular disease diagnostics, prevention and treatment, about half of the affected patients reportedly die within five years of receiving a diagnosis because of a variety of reasons. including genetic and environmental factors. Researchers said the use of AI and machine learning can accelerate our ability to identify genes that have important implications for cardiovascular disease, which can lead to improvements in diagnoses and treatment. 

Researchers from IFH analyzed healthy patients and patients diagnosed with cardiovascular disease and used AI and machine-learning models to investigate the genes known to be associated with the most common manifestations of cardiovascular disease, including atrial fibrillation and heart failure

They identified a group of genes that were significantly associated with having cardiovascular disease. Researchers also found significant differences among race, gender and age factors based on the cardiovascular disease. While age and gender factors correlated to heart failure, age and race factors correlated to atrial fibrillation. For example, in the patients examined, the older the patient, the more likely they were to have a cardiovascular disease. 

“Timely understanding and precise treatment of cardiovascular disease will ultimately benefit millions of individuals by reducing the high risk for mortality and improving the quality of life,” said Ahmed, who is an assistant professor with the Department of Medicine at Rutgers Robert Wood Johnson Medical School

Researchers said future research should extend this approach by analyzing the full set of genes in patients with cardiovascular disease which may reveal important biomarkers and risk factors associated with the cardiovascular disease susceptibility. 


Related Content

News | Cardiovascular Clinical Studies

March 22, 2023 — Ancora Heart, Inc., a privately-held Santa Clara, CA-based company developing a completely ...

Home March 22, 2023
Home
News | Cardiovascular Clinical Studies

March 21, 2023 — The first platform to combine real-world cardiology data from millions of people in multiple European ...

Home March 21, 2023
Home
News | Cardiovascular Clinical Studies

March 13, 2023 — BioCardia, Inc., developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2023
Home
News | Cardiovascular Clinical Studies

March 8, 2023 — A unique community-based partnership, the African American Heart Study, will be conducted to measure the ...

Home March 08, 2023
Home
News | Cardiovascular Clinical Studies

March 6, 2023 — A multifaceted intervention to improve prescribing practices increased the likelihood that patients with ...

Home March 06, 2023
Home
News | Cardiovascular Clinical Studies

March 5, 2023 — Providing medications for chronic diseases—for example, cholesterol-lowering, blood pressure and ...

Home March 05, 2023
Home
News | Cardiovascular Clinical Studies

March 5, 2023 — The number of deaths and disabling strokes among patients at low surgical risk who were treated with ...

Home March 05, 2023
Home
News | Cardiovascular Clinical Studies

March 5, 2023 — In the largest randomized trial conducted to compare minimally invasive and conventional cardiac ...

Home March 05, 2023
Home
News | Cardiovascular Clinical Studies

February 20, 2023 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...

Home February 20, 2023
Home
News | Cardiovascular Clinical Studies

February 16, 2023 — Traffic noise may play an essential role in the development and deterioration of ischemic heart ...

Home February 16, 2023
Home
Subscribe Now